GlassScriptPhysician profile
Ellery S Murray
NPI 1669251971
$2,924.55
in general payments reported to CMS, 2019-2025
22 companies · $1,347 in 2025
The $1,347 reported for 2025 was more than what 89% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $271 · 2024: $1,307 · 2025: $1,347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,925.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,924.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $675.02 | 2023-2025 | |
| Collegium Pharmaceutical, INC. | $304.75 | 2023-2025 | Xtampza |
| Novo Nordisk INC | $240.35 | 2023-2025 | Wegovy |
| Valinor Pharma, LLC | $237.20 | 2024-2025 | Movantik |
| Lilly USA, LLC | $185.42 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Boston Scientific Corporation | $179.97 | 2025 | Intracept |
| Vertex Pharmaceuticals Incorporated | $143.07 | 2024-2025 | |
| Painteq LLC | $121.79 | 2024 | Painteq |
| Medtronic, INC. | $108.29 | 2024 | Intellis Adaptivestim |
| Averitas Pharma INC. | $108.16 | 2024-2025 | Qutenza |
| Pfizer INC. | $93.54 | 2024-2025 | |
| Nevro Corp. | $92.85 | 2024 | Senza |
| Tersera Therapeutics LLC | $80.04 | 2024-2025 | Prialt |
| Scilex Pharmaceuticals INC. | $74.61 | 2024 | |
| Lundbeck LLC | $69.72 | 2024-2025 | Vyepti |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $61.44 | 2023 | Xeomin |
| Indivior INC. | $38.68 | 2025 | Sublocade |
| Spinal Simplicity, LLC | $36.61 | 2024 | Ha Minuteman G3-R |
| Curonix LLC | $22.14 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Ibsa Pharma INC. | $20.74 | 2024 | Tirosint, Licart |
| Azurity Pharmaceuticals, INC. | $15.30 | 2025 | Horizant |
| Currax Pharmaceuticals LLC | $14.86 | 2025 | Contrave |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellery Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.